| scholarly article | Q13442814 |
| P50 | author | Michael Schroeder | Q82816646 |
| P2093 | author name string | Simone Daminelli | |
| V Joachim Haupt | |||
| Matthias Reimann | |||
| P2860 | cites work | Unraveling protein networks with power graph analysis | Q21145374 |
| Semantic Similarity for Automatic Classification of Chemical Compounds | Q21563489 | ||
| DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 | ||
| The Protein Data Bank | Q24515306 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| GoPubMed: exploring PubMed with the Gene Ontology | Q24530535 | ||
| Database resources of the National Center for Biotechnology Information | Q24610877 | ||
| DrugBank 3.0: a comprehensive resource for 'omics' research on drugs | Q24612505 | ||
| Update of TTD: Therapeutic Target Database | Q24643206 | ||
| Predicting new molecular targets for known drugs | Q24649687 | ||
| The human disease network | Q24678240 | ||
| The Blue Obelisk-interoperability in chemical informatics | Q27062363 | ||
| SuperTarget and Matador: resources for exploring drug-target relationships | Q27136964 | ||
| Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition | Q27643006 | ||
| Structural and thermodynamic analysis of thrombin:suramin interaction in solution and crystal phases | Q27654512 | ||
| Crystal Structure of Cardiac-specific Histone Methyltransferase SmyD1 Reveals Unusual Active Site Architecture | Q27664997 | ||
| PubChem as a public resource for drug discovery | Q28111749 | ||
| Do structurally similar molecules have similar biological activity? | Q28220975 | ||
| Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica | Q28292996 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| ChEMBL: a large-scale bioactivity database for drug discovery | Q28315179 | ||
| A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology | Q28472464 | ||
| Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification | Q28474912 | ||
| Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis | Q28475676 | ||
| Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells | Q28476510 | ||
| A side effect resource to capture phenotypic effects of drugs | Q29387552 | ||
| A human phenome-interactome network of protein complexes implicated in genetic disorders | Q29614448 | ||
| Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
| Drug target identification using side-effect similarity | Q29615103 | ||
| The Protein Data Bank | Q29616068 | ||
| A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites | Q30362321 | ||
| Method for comparing the structures of protein ligand-binding sites and application for predicting protein-drug interactions. | Q30367299 | ||
| Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments. | Q30368616 | ||
| SMAP-WS: a parallel web service for structural proteome-wide ligand-binding site comparison | Q30389394 | ||
| Finding new tricks for old drugs: an efficient route for public-sector drug discovery | Q33229063 | ||
| Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit | Q33323081 | ||
| Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework | Q33597328 | ||
| A quantitative approach to study indirect effects among disease proteins in the human protein interaction network | Q33644962 | ||
| Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery | Q33649365 | ||
| Identification of small molecules enhancing autophagic function from drug network analysis | Q33712703 | ||
| Systematic evaluation of drug-disease relationships to identify leads for novel drug uses | Q33718713 | ||
| The power of protein interaction networks for associating genes with diseases | Q33785541 | ||
| ProBiS: a web server for detection of structurally similar protein binding sites | Q33957473 | ||
| Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice | Q34137151 | ||
| The Comparative Toxicogenomics Database: update 2011. | Q34456573 | ||
| New uses for old drugs | Q34661227 | ||
| Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability | Q35057543 | ||
| Exploiting drug-disease relationships for computational drug repositioning | Q35109885 | ||
| The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v) 1.2 channels | Q35593075 | ||
| Cutting the cost of drug development? | Q35732868 | ||
| Network properties of genes harboring inherited disease mutations | Q36670355 | ||
| Proarrhythmic potential of antimicrobial agents | Q37153636 | ||
| Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks | Q37202770 | ||
| A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery | Q37206373 | ||
| Sex hormones and modulation of immunity against leishmaniasis | Q37383504 | ||
| Visualizing the drug target landscape | Q37617737 | ||
| Unveiling the role of network and systems biology in drug discovery | Q37684484 | ||
| Computational polypharmacology with text mining and ontologies | Q37816466 | ||
| Old friends in new guise: repositioning of known drugs with structural bioinformatics | Q37858324 | ||
| Antimalarial activity in mice of resveratrol derivative from Pleuropterus ciliinervis | Q38500340 | ||
| Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling | Q39618565 | ||
| Antioxidant, anti-inflammatory and anti-influenza properties of components from Chaenomeles speciosa | Q39628524 | ||
| Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase | Q39643271 | ||
| Inhibition of influenza virus replication by plant-derived isoquercetin | Q39657984 | ||
| Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines | Q39664750 | ||
| Antiproliferative and pro-apoptotic effects of quercetin on human pancreatic carcinoma cell lines EPP85-181P and EPP85-181RDB. | Q39673100 | ||
| Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole | Q39802585 | ||
| Mechanism of interference by haemolysis in the cardiac troponin T immunoassay | Q40360562 | ||
| Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents | Q40877590 | ||
| PROMISCUOUS: a database for network-based drug-repositioning | Q41578922 | ||
| Leukotriene A4 hydrolase in the human B-lymphocytic cell line Raji: indications of catalytically divergent forms of the enzyme | Q41684015 | ||
| Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum. | Q41919388 | ||
| Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib | Q42559886 | ||
| The cardioprotective effects of a combination of quercetin and α-tocopherol on isoproterenol-induced myocardial infarcted rats | Q42750575 | ||
| Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension. | Q42942992 | ||
| Computational approaches for drug repositioning and combination therapy design. | Q43015433 | ||
| In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes | Q43223042 | ||
| Lessons from 60 years of pharmaceutical innovation | Q43447062 | ||
| Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. | Q44429241 | ||
| Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes | Q44875024 | ||
| In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. | Q44890581 | ||
| Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? | Q45186889 | ||
| Synthesis and antiparasitic properties of new 4-N-benzylamino-4-hetarylbut-1-enes. | Q45240707 | ||
| Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid | Q46185521 | ||
| Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships | Q46855187 | ||
| Effects of protein kinase and phosphatidylinositol-3 kinase inhibitors on growth and ultrastructure of Trypanosoma cruzi | Q46961893 | ||
| Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents | Q47866965 | ||
| Protein-protein interaction network evaluation for identifying potential drug targets. | Q51694945 | ||
| Chronic inflammation in Alzheimer's disease offers therapeutic opportunities. | Q52017663 | ||
| Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro. | Q53540561 | ||
| P433 | issue | 7 | |
| P921 | main subject | drug repositioning | Q5308921 |
| P304 | page(s) | 778-788 | |
| P577 | publication date | 2012-04-26 | |
| P1433 | published in | Integrative Biology | Q1524032 |
| P1476 | title | Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network | |
| P478 | volume | 4 |
| Q28552224 | An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations |
| Q38340254 | Application of text mining in the biomedical domain |
| Q28534178 | Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key |
| Q64104050 | Drug prioritization using the semantic properties of a knowledge graph |
| Q33589478 | Drug repurposing: a better approach for infectious disease drug discovery? |
| Q38816088 | Drug target prioritization by perturbed gene expression and network information |
| Q28643758 | Inferring drug-disease associations based on known protein complexes |
| Q30763631 | Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation |
| Q31032576 | Integrative methods for analyzing big data in precision medicine |
| Q54453411 | Investigating flavonoids as molecular templates for the design of small-molecule inhibitors of cell signaling. |
| Q34427893 | Network Analysis of Cancer-focused Association Network Reveals Distinct Network Association Patterns |
| Q34064935 | Network-based analysis reveals distinct association patterns in a semantic MEDLINE-based drug-disease-gene network |
| Q38089597 | Network-based drug repositioning |
| Q28601372 | Network-based in silico drug efficacy screening |
| Q35540850 | Network-based inference methods for drug repositioning |
| Q47867878 | Pioneering topological methods for network-based drug-target prediction by exploiting a brain-network self-organization theory. |
| Q39226874 | Rectifying cancer drug discovery through network pharmacology |
| Q27008867 | Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review |
| Q48158859 | Systematic identification of latent disease-gene associations from PubMed articles |
| Q38473775 | The integrated disease network |
| Q58761782 | Using predicate and provenance information from a knowledge graph for drug efficacy screening |
Search more.